Virtu Financial LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 23 filers reported holding PROQR THRAPEUTICS N V in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2023$201
-99.6%
94,564
+54.0%
0.02%
+425.0%
Q2 2022$48,000
-48.9%
61,425
+342.4%
0.00%
-55.6%
Q2 2021$94,000
+46.9%
13,883
+5.6%
0.01%
+200.0%
Q3 2017$64,00013,1500.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2017
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 748,861$6,815,0002.37%
Opus Point Partners Management, LLC 138,461$1,260,0001.86%
RTW INVESTMENTS, LP 3,722,950$33,879,0001.81%
Kerrisdale Advisers, LLC 465,580$4,237,0001.52%
DAFNA Capital Management LLC 261,521$2,380,0000.90%
SPHERA FUNDS MANAGEMENT LTD. 470,000$4,277,0000.58%
Artal Group S.A. 1,300,000$11,830,0000.48%
Orbimed Advisors 1,382,502$12,581,0000.20%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,000$511,0000.19%
ALTRINSIC GLOBAL ADVISORS LLC 201,360$1,832,0000.08%
View complete list of PROQR THRAPEUTICS N V shareholders